Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects
Clinical trial NCT02954263 · COMPLETED
Trial details
- NCT number
- NCT02954263
- Sponsor
- Theravance Biopharma
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-01
- Primary completion
- 2017-02-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.